4.3 Article

'A Most Protean Disease': Aligning Medical Knowledge of Modern Influenza, 1890-1914

期刊

MEDICAL HISTORY
卷 56, 期 4, 页码 481-510

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/mdh.2012.29

关键词

-

资金

  1. Wellcome Trust

向作者/读者索取更多资源

This article reconstructs the process of defining influenza as an infectious disease in the contexts of British medicine between 1890 and 1914. It shows how professional agreement on its nature and identity involved aligning different forms of knowledge produced in the field (public health), in the clinic (metropolitan hospitals) and in the laboratory (bacteriology). Two factors were crucial to this process: increasing trust in bacteriology and the organisation of large-scale collective investigations into influenza by Britain's central public authority, the Medical Department of the Local Government Board. These investigations integrated epidemiological, clinical and bacteriological evidence into a new definition of influenza as a specific infection, in which a germ - Bacillus influenzae - was determined as playing a necessary but not sufficient role in its aetiology, transmission and pathogenesis. In defining 'modern influenza', bacteriological concepts and techniques were adapted to and selectively incorporated into existing clinical, pathological and epidemiological approaches. Mutual alignment thus was crucial to its construction and, more generally, to shaping developing relationships between laboratory, clinical and public health medicine in turn-of-the-century Britain. While these relationships were marked by tension and conflict, they were also characterised by important patterns of convergence, in which the problems, interests and practices of public health professionals, clinicians and laboratory pathologists were made increasingly commensurable. Rather than retrospectively judge the late nineteenth-century definition of influenza as being based on the wrong microbe, this article argues for the need to examine how it was established through a particular alignment of medical knowledge, which then underpinned medical approaches to the disease up to and beyond the devastating 1918-19 pandemic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial

Seth D. Crockett, Elizabeth L. Barry, Leila A. Mott, Dennis J. Ahnen, Douglas J. Robertson, Joseph C. Anderson, Kristen Wallace, Carol A. Burke, Robert S. Bresalier, Jane C. Figueiredo, Dale C. Snover, John A. Baron

Article Oncology

Body mass index, calcium supplementation and risk of colorectal adenomas

Elizabeth L. Barry, Jennifer L. Lund, Daniel Westreich, Leila A. Mott, Dennis J. Ahnen, Gerald J. Beck, Roberd M. Bostick, Robert S. Bresalier, Carol A. Burke, Timothy R. Church, Judy R. Rees, Douglas J. Robertson, John A. Baron

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Medicine, Research & Experimental

Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study

Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Gastroenterology & Hepatology

Patients with Non-Hodgkin's Lymphoma Are at Risk of Adenomatous Colon Polyps

Hamzah Abu-Sbeih, Ellie Chen, Osman Ahmed, Niharika Mallepally, Phillip Lum, Wei Qiao, Hun Ju Lee, Robert Bresalier, Lan Sun Wang, Brian Weston, Gottumukkala S. Raju, Yinghong Wang

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Gastroenterology & Hepatology

Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors

Tenglong Tang, Hamzah Abu-Sbeih, Wenyi Luo, Phillip Lum, Wei Qiao, Robert S. Bresalier, David M. Richards, Yinghong Wang

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Rate of colorectal neoplasia in patients with Hodgkin lymphoma

H. Abu-Sbeih, F. S. Ali, T. Tang, E. Coronel, H. J. Lee, M. Pande, R. S. Bresalier, G. S. Raju, Y. Wang

COLORECTAL DISEASE (2020)

Editorial Material Gastroenterology & Hepatology

Human Microbiome in Health and Disease: The Good, the Bad, and the Bugly

Robert S. Bresalier, Robert S. Chapkin

DIGESTIVE DISEASES AND SCIENCES (2020)

Article Medicine, Research & Experimental

A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade

Leonardo Mirandola, Maurizio Chiriva-Internati, Robert Bresalier, Lucia Piccotti, Fabio Grizzi, Francesco M. Marincola

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Letter Surgery

PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions

Fabio Grizzi, Dorina Qehajaj, Daniel Yiu, Robert S. Bresalier, Maurizio Chiriva-Internati

SURGERY TODAY (2020)

Article Oncology

Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation

Robert S. Bresalier, William M. Grady, Sanford D. Markowitz, Hans Jorgen Nielsen, Surinder K. Batra, Paul D. Lampe

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Article Medical Laboratory Technology

Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures

Niels Lech Pedersen, Mathias Mertz Petersen, Jon J. Ladd, Paul D. Lampe, Robert S. Bresalier, Gerard J. Davis, Christina Demuth, Sarah O. Jensen, Claus L. Andersen, Linnea Ferm, Ib J. Christensen, Hans J. Nielsen

CLINICA CHIMICA ACTA (2020)

Article Gastroenterology & Hepatology

Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression

Daoyan Wei, Liang Wang, Yi Liu, Margarete A. A. Hafley, Lin Tan, Philip L. L. Lorenzi, Peiying Yang, Xiangsheng Zuo, Robert S. S. Bresalier

Summary: The inactivation of vitamin D/VDR signaling may contribute to the malignant phenotype of pancreatic ductal adenocarcinoma (PDA) and altered expression of oncoprotein mucin 1 (MUC1) may be involved in drug resistance of cancer cells. The study found that vitamin D/VDR signaling regulates the expression and function of MUC1 and can enhance the sensitivity of PDA cells to gemcitabine treatment.

DIGESTIVE DISEASES AND SCIENCES (2023)

Article Gastroenterology & Hepatology

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles

Robert S. Bresalier, Carlo Senore, Graeme P. Young, James Allison, Robert Benamouzig, Sally Benton, Patrick M. M. Bossuyt, Luis Caro, Beatriz Carvalho, Han-Mo Chiu, Veerle M. H. Coupe, Willemijn de Klaver, Clasine Maria de Klerk, Evelien Dekker, Sunil Dolwani, Callum G. Fraser, William Grady, Lydia Guittet, Samir Gupta, Stephen P. Halloran, Ulrike Haug, Geir Hoff, Steven Itzkowitz, Tim Kortlever, Anastasios Koulaouzidis, Uri Ladabaum, Beatrice Lauby-Secretan, Marcis Leja, Bernard Levin, Theodore Robert Levin, Finlay Macrae, Gerrit A. Meijer, Joshua Melson, Colm O'Morain, Susan Parry, Linda Rabeneck, David F. Ransohoff, Roque Saenz, Hiroshi Saito, Silvia Sanduleanu-Dascalescu, Robert E. Schoen, Kevin Selby, Harminder Singh, Robert J. C. Steele, Joseph J. Y. Sung, Erin Leigh Symonds, Sidney J. Winawer

Summary: New non-invasive tests for colorectal cancer (CRC) are emerging, making it challenging to conduct trials with mortality reduction as the main goal. A formal consensus approach involving experts resulted in the revision of previously established principles and the emergence of twelve new principles. The effectiveness of a new test can be evaluated by comparing it with an established non-invasive test, with the faecal immunochemical test considered as the appropriate comparator. Flexible adjustment of the new test's positivity threshold is desirable to meet different screening goals and requirements. A four-phased approach is proposed for the evaluation of new tests, including small studies, prospective estimation of accuracy, evaluation in screening populations, and monitoring for missed lesions.
Article Oncology

Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia

Hamzah Abu-Sbeih, Faisal S. Ali, Wei Qiao, Phillip Lum, Mehnaz A. Shafi, Robert S. Bresalier, Ernest Hawk, Gottumukkala S. Raju, Yinghong Wang

JOURNAL OF CANCER (2020)

Article Gastroenterology & Hepatology

Patients with breast cancer may be at higher risk of colorectal neoplasia

Hamzah Abu-Sbeih, Faisal S. Ali, Phillip S. Ge, Carlos H. Barcenas, Phillip Lum, Wei Qiao, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang

ANNALS OF GASTROENTEROLOGY (2019)

暂无数据